NCT06697548

Brief Summary

This study will test the effectiveness of emerging conservative interventions for treatment of chronic pelvic pain (CPP) that can be performed without intravaginal specialization. Participants with CPP will be randomly assigned to one of three groups. The first group will receive treatment based on what they normally would receive, including medications, education, and exercise (Usual Care Group). The second group will receive contemporary non-vaginal treatment including manual therapy, dry needling, and specific breathing training (Emerging Field-expedient Care Group). The third group will receive intravaginal treatment by a pelvic health specialist (Gold-standard Intravaginal Specialist Care Group). Participants will be asked about their pain and symptoms and have measurements taken of their pelvic and back muscles after 1, 3, 6, and 12 months. In addition to seeing which treatments work best, clinical decision tools (using medical and trauma history along with clinical examination) will be developed to identify women with CPP likely to respond favorably to non-vaginal conservative interventions. This study will help determine the best non-vaginal treatment strategies for women with CPP and help clinicians quickly determine which patients are likely to benefit from treatment by non-pelvic health physical therapists (e.g., in theater), vs. patients who should be referred for pelvic health specialty care.

Trial Health

63
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
300

participants targeted

Target at P75+ for not_applicable

Timeline
26mo left

Started Jan 2025

Longer than P75 for not_applicable

Geographic Reach
1 country

2 active sites

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress39%
Jan 2025Jun 2028

First Submitted

Initial submission to the registry

November 18, 2024

Completed
2 days until next milestone

First Posted

Study publicly available on registry

November 20, 2024

Completed
1 month until next milestone

Study Start

First participant enrolled

January 1, 2025

Completed
3.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2028

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2028

Last Updated

November 20, 2024

Status Verified

November 1, 2024

Enrollment Period

3.4 years

First QC Date

November 18, 2024

Last Update Submit

November 19, 2024

Conditions

Keywords

Pelvic healthChronic pelvic painPhysical therapyMilitarywomens health

Outcome Measures

Primary Outcomes (2)

  • The Pelvic Floor Distress Inventory (PFDI-20)

    The Pelvic Floor Distress Inventory (PFDI-20) is a 20-item questionnaire that assesses the frequency and severity of pelvic floor symptoms. It consists of 3 subscales: the pelvic floor distress inventory 6 (POPDI-6), the colorectal anal distress inventory 8 (CRADI-8), and the urinary distress inventory 6 (UDI-6). Each question is rated on a scale of 0-4 with 0 representing "no symptoms," and 4 representing "quite a bit." Higher scores represent more bothersome symptoms.

    1 week and 1, 3, 6, and 12 months

  • The Genitourinary Pain Index (GUPI)

    The Genitourinary Pain Index (GUPI) is 9-item questionnaire that assesses presence, location, frequency, quality and quantity of genitourinary pain in both men and women.

    1 week and 1, 3, 6, and 12 months

Secondary Outcomes (5)

  • Numeric pain rating scale (NPRS)

    1 week and 1, 3, 6, and 12 months

  • Pelvic Floor Muscle Tone

    1 week and 1, 3, 6, and 12 months

  • Superficial Lumbopelvic Muscle Tone

    1 week and 1, 3, 6, and 12 months

  • Pelvic Floor Pain Sensitivity

    1 week and 1, 3, 6, and 12 months

  • Lumbopelvic Muscle Pain Sensitivity

    1 week and 1, 3, 6, and 12 months

Study Arms (3)

Usual Care

ACTIVE COMPARATOR

Usual Care Group will receive their current medical management care along with study-specific patient education and progressive home exercise.

Other: Lumbopelvic and Hip Therapeutic ExerciseOther: Chronic Pelvic Pain Education

Emerging Field-expedient Care

EXPERIMENTAL

Emerging Field-expedient Care Group will receive a combination of emerging nonvaginal interventions aimed at normalizing sensory, motor, and autonomic nervous system dysfunction including pain neuroscience education, diaphragmatic breathing training, and lumbopelvic manual therapy and dry needing treatment

Other: Pain Neuroscience EducationOther: Lumbopelvic and Hip Therapeutic ExerciseOther: Extrapelvic Manual TherapyOther: Extrapelvic Dry NeedlingOther: Deep Paced Diaphragmatic Breathing TrainingOther: Chronic Pelvic Pain Education

Gold-standard Intravaginal Specialist Care

ACTIVE COMPARATOR

Gold-standard Intravaginal Specialist Care Group will receive tailored intravaginal and intrarectal manual therapy and biofeedback intervention by a pelvic-health specialist.

Other: Pain Neuroscience EducationOther: Lumbopelvic and Hip Therapeutic ExerciseOther: Deep Paced Diaphragmatic Breathing TrainingOther: Chronic Pelvic Pain EducationOther: Intravaginal and intrarectal pelvic floor physical therapy

Interventions

Participants will watch and discuss a short (5-minute) standardized pain neuroscience education video with their treating provider. The video explains and illustrates how chronic pain is different than acute pain in that it concerns nervous system hypersensitivity more than local tissue damage. Pain neuroscience education principles from the video will then be used to throughout all interventions to coach the participants through graded exposure of activities that may have previously been painful or provoked anxiety.

Emerging Field-expedient CareGold-standard Intravaginal Specialist Care

These motor control exercises will focus on proprioception, coordination, and sensorimotor control training and include progressive exercises that focus on transversus abdominis, lumbar multifidus, diaphragmatic, pelvic floor muscles, and deep hip stabilizers. Exercises will progress from more stabilized (e.g., pelvic tilt, cat and cow) to less stabilized and more dynamic and functional (e.g., forward bending, eccentric squat) to mimic the demands of work duty. Exercise will be trained and progressed during the clinical visits and be performed daily at home.

Emerging Field-expedient CareGold-standard Intravaginal Specialist CareUsual Care

Thrust and non-thrust manual therapy will be applied to the lumbar facet, sacroiliac, and hip joints based upon the clinical exam in a semi-standardized manner

Emerging Field-expedient Care

Dry needling treatment to muscles of the lumbopelvic and upper thigh regions in a semi-standardized manner based upon a palpatory examination. The palpatory examination will include the erector spinae, lumbar multifidi, gluteus medius/minimus, piriformis, illiacus, and hip adductor muscles.

Emerging Field-expedient Care

The breathing intervention will start with education describing the link between the diaphragm and the pelvic floor to include awareness of any breath holding patterns and finding positions that facilitate expansion of the ribs, abdominals, and pelvic floor muscles with inhalation. Then progressive training will be given to encourage deep breathing at a pace of approximately 6 breaths per minute.

Emerging Field-expedient CareGold-standard Intravaginal Specialist Care

During the first visit, participants will receive and briefly discuss the 2023 standardized patient educational handout created by the International Pelvic Pain Society with their treating provider. The educational handout describes chronic pelvic pain etiology, typical symptoms, examination, and treatments.

Emerging Field-expedient CareGold-standard Intravaginal Specialist CareUsual Care

Superficial vulvar, perineal and intravaginal manual therapy and biofeedback utilizing commonly used techniques in previous research selected based on identified impairments from the pelvic floor examination will be performed.

Gold-standard Intravaginal Specialist Care

Eligibility Criteria

Age18 Years - 50 Years
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • \. Pain of at least 3 months duration in the abdominal-lumbopelvic area, defined as below the umbilicus, between the two ilia, and above the pubic symphysis including the vulvar, perineal, and vaginal regions.

You may not qualify if:

  • Sign that pelvic pain may be due to other serious medical issue (recent history of abdominal pelvic surgery, current infection, disrupted tissue integrity, neoplasm, or history of radiation to the pelvic floor tissue or the tissues being measured for stiffness).
  • Chronic debilitating medical conditions (e.g., fibromyalgia, lupus, complex regional pain syndrome, multiple sclerosis or other progressive neurologic condition).
  • Currently pregnant or pregnancy in the last 6 months.
  • Body mass index over 33 (Waco participants only due to limitation of the instrumentation).
  • Soldiers in an Advanced Individual Training (AIT) status.
  • Previous intervention to address lumbopelvic muscle stiffness or pain such as dry needling, injections, or soft tissue intervention of any kind in the past 6 months.
  • Inability to read English at an 8th grade reading level (any participant unable to read the informed consent form, which will be written at an 8th grade level).
  • Inability to legally provide informed consent for any other reason.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

U.S. Army Medical Center of Excellence (MEDCoE)

San Antonio, Texas, 78234, United States

Location

Baylor University

Waco, Texas, 76701, United States

Location

Central Study Contacts

Shane Koppenhaver, PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

November 18, 2024

First Posted

November 20, 2024

Study Start

January 1, 2025

Primary Completion (Estimated)

June 1, 2028

Study Completion (Estimated)

June 1, 2028

Last Updated

November 20, 2024

Record last verified: 2024-11

Data Sharing

IPD Sharing
Will not share

Depending upon where the findings of this study are published, sharing individual participant data might not be feasible.

Locations